Characteristics | n | TFPI-2 | P | ||||
---|---|---|---|---|---|---|---|
 |  | - | + | ++ | +++ | ++++ |  |
normal | 12 | 0 | 0 | 0 | 2 | 10 | < 0.001 |
CIN | 48 | 0 | 3 | 19 | 18 | 8 | Â |
   CIN I | 21 | 0 | 0 | 3 | 10 | 8 | < 0.001 |
   CIN II/III | 27 | 0 | 3 | 16 | 8 | 0 |  |
ICC | 68 | 23 | 25 | 19 | 1 | 0 | Â |
   WICC | 13 | 2 | 5 | 6 | 0 | 0 | 0.474 |
   MICC | 39 | 13 | 15 | 10 | 1 | 0 |  |
   PICC | 16 | 8 | 5 | 3 | 0 | 0 |  |
Histology | Â | Â | Â | Â | Â | Â | Â |
   SCC | 61 | 19 | 22 | 19 | 1 | 0 | 0.304 |
   ACC | 7 | 4 | 3 | 0 | 0 | 0 |  |
Figo stage | Â | Â | Â | Â | Â | Â | Â |
   I | 37 | 5 | 17 | 13 | 1 | 0 | 0.003 |
   II | 31 | 18 | 8 | 6 | 0 | 0 |  |
LN metastasis | Â | Â | Â | Â | Â | Â | Â |
   Absent | 51 | 13 | 19 | 18 | 1 | 0 | 0.037 |
   Present | 17 | 10 | 6 | 1 | 0 | 0 |  |
HPV status | Â | Â | Â | Â | Â | Â | Â |
   Absent | 38 | 1 | 6 | 9 | 9 | 13 | < 0.001 |
   Present | 90 | 26 | 22 | 25 | 12 | 5 |  |